Statins, Low-Density Lipoprotein Cholesterol, and Risk of Ca

General health & wellness related research
Post Reply
User avatar
galapogos
GM, Team Biceps
Posts: 9980
Joined: Tue Jan 13, 2004 2:35 am
Enter the middle number in the list(3): 0
No curling in the: curl rack
Location: In front of my computer
Contact:

Statins, Low-Density Lipoprotein Cholesterol, and Risk of Ca

Post by galapogos »

http://content.onlinejacc.org/cgi/content/abstract/j.jacc.2008.06.037v1

Objectives: We sought to assess whether statin-mediated reductions in low-density lipoprotein cholesterol (LDL-C) are associated with an increased risk of cancer.

Background: We recently reported an inverse association between on-treatment LDL-C levels and incident cancer in statin-treated patients enrolled in large randomized controlled trials, raising concern that LDL-C lowering by statins may increase cancer risk. However, meta-analyses suggest a neutral overall effect of statins on incident cancer.

Methods: A systematic literature search identified 15 eligible randomized controlled trials of statins with ≥1,000 person-years of follow-up that provided on-treatment LDL-C levels and rates of incident cancers (19 statin and 14 control arms, 437,017 person-years cumulative follow-up, and 5,752 incident cancers).

Results: In the statin arms, meta-regression analysis demonstrated an inverse association between on-treatment LDL-C and incident cancer, with an excess of 2.2 (95% confidence interval: 0.7 to 3.6) cancers per 1,000 person-years for every 10 mg/dl decrement in on-treatment LDL-C (p = 0.006). The corresponding difference among control arms was 1.2 (95% confidence interval: –0.2 to 2.7, p = 0.09). Compared with the control arms, the statin regression line was significantly shifted leftward, such that similar rates of incident cancer were associated with lower on-treatment LDL-C (p < 0.05). Meta-regression demonstrated that statins lack an effect on cancer risk across all levels of on-treatment LDL-C.

Conclusions: There is an inverse association between on-treatment LDL-C and incident cancer. However, statins, despite producing marked reductions in LDL-C, are not associated with an increased risk of cancer.

Post Reply